Literature DB >> 21204805

A duplication in 1q21.3 in a family with early onset and childhood absence epilepsy.

Hiltrud Muhle1, Ines Steinich, Sarah von Spiczak, Andre Franke, Yvonne Weber, Holger Lerche, Michael Wittig, Simone Heidemann, Arvid Suls, Peter de Jonghe, Carla Marini, Renzo Guerrini, Ingrid E Scheffer, Samuel F Berkovic, Ulrich Stephani, Reiner Siebert, Thomas Sander, Ingo Helbig, Holger Tönnies.   

Abstract

Early onset absence epilepsy (EOAE) starting before the age of 4 years constitutes a rare subgroup of the idiopathic generalized epilepsies (IGEs). A strong genetic component in IGE has been suggested by twin and family studies. We describe a boy with absence seizures starting at the age of 9 months whose parents both had childhood absence epilepsy. A 192-kb duplication in 1q21.3 was identified in the proband and his father, encompassing the gene CHRNB2 coding for the β-2 subunit of the nicotinic acetylcholine receptor and the gene ADAR coding for adenosine deaminase, an enzyme responsible for RNA editing. Both are candidate genes for seizure disorders. The duplication was not identified in 191 independent IGE patients (93 EOAE; 98 classical IGE) or in 1,157 population controls. Wiley Periodicals, Inc.
© 2010 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21204805     DOI: 10.1111/j.1528-1167.2010.02712.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

1.  Microdeletion of chromosome 1q21.3 in fraternal twins is associated with mental retardation, microcephaly, and epilepsy.

Authors:  Fatma Mujgan Sonmez; Eyyup Uctepe; Dilek Aktas; Mehmet Alikasifoglu
Journal:  Intractable Rare Dis Res       Date:  2017-02

Review 2.  Epilepsy and the new cytogenetics.

Authors:  John C Mulley; Heather C Mefford
Journal:  Epilepsia       Date:  2011-01-26       Impact factor: 5.864

Review 3.  Adenosine receptors and epilepsy: current evidence and future potential.

Authors:  Susan A Masino; Masahito Kawamura; David N Ruskin
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

Review 4.  The molecular biology of genetic-based epilepsies.

Authors:  Hao Deng; Xiaofei Xiu; Zhi Song
Journal:  Mol Neurobiol       Date:  2013-08-10       Impact factor: 5.590

5.  Management of Severe Developmental Regression in an Autistic Child with a 1q21.3 Microdeletion and Self-Injurious Blindness.

Authors:  Cora Cravero; Vincent Guinchat; Jean Xavier; Camille Meunier; Lautaro Diaz; Cyril Mignot; Diane Doummar; Sandra Chantot-Bastaraud; Angèle Consoli; David Cohen
Journal:  Case Rep Psychiatry       Date:  2017-05-25

Review 6.  From Physiology to Pathology of Cortico-Thalamo-Cortical Oscillations: Astroglia as a Target for Further Research.

Authors:  Davide Gobbo; Anja Scheller; Frank Kirchhoff
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

7.  Genetic variations and associated pathophysiology in the management of epilepsy.

Authors:  John C Mulley; Leanne M Dibbens
Journal:  Appl Clin Genet       Date:  2011-08-08

8.  De Novo 1q21.3q22 Duplication Revaluation in a "Cold" Complex Neuropsychiatric Case with Syndromic Intellectual Disability.

Authors:  Roberta Milone; Roberta Scalise; Rosa Pasquariello; Stefano Berloffa; Ivana Ricca; Roberta Battini
Journal:  Genes (Basel)       Date:  2021-03-31       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.